Search Results for:

Stable rate of EC’ use in Spain

October 2022. The Spanish Society of Contraception (SEC) just published the findings of the Contraception in Spain 2022 Survey (“Anticoncepcion en España 2022”).  With this survey SEC aims to strengthen the knowledge on the female population’s habits with regards to contraceptive methods use in Spain. The survey was conducted between July 21 and August 17,…

Luxembourg: webinar Macontraception

September 2022. FRENCH: Le 26 septembre (Journée mondiale de la contraception), le Centre national de référence pour la promotion de la santé affective et sexuelle (CESAS) du Luxembourg, organise le webinaire macontraception.lu. L’ECEC est heureuse de participer avec une présentation sur les progrès réalisés et les défis restants pour l’accès à la contraception d’urgence en…

“Let’s talk about emergency contraception: Strategies to scale up access” 

August 2022. The Asia Pacific and the European EC consortia (APCEC and ECEC) are organizing a casual gathering within FIAPAC’s upcoming conference, to talk about emergency contraception (EC).  Please join us for lunch at the 14th FIAPAC Conference in Riga, on September 10th for a conversation on how to scale up access to emergency contraception…

Catalonia: new EC provision protocol for public health services

July 2022. The Catalan Health Department just published a new protocol for emergency contraception (EC) provision in public health services. The protocol now includes LNG and UPA EC pills, and also the insertion of the Cu-IUD. According to data estimates included in the document, in Catalonia in 2020 about 89% of EC pills were sold…

Updated recommendation on LNG dosages and higher BMI and weights

June 2022. Our sister organization, the American Society for Emergency Contraception (ASEC), just updated its factsheet on EC efficacy and body weight, an excellent summary of the current understanding and recommendations on this issue. This update is based on the publication by Dr. Alison Edelman and team of “Double Dosing Levonorgestrel-Based Emergency Contraception for Individuals…

Use of emergency contraception after sexual assault

May 2022. The International Association of Forensic Nurses (IAFN) recommends that EC be immediately offered and available to all female (or trans-male) victims of sexual assault or abuse of reproductive age or stage who choose to use EC as a means of protection from unintended pregnancy. Read the whole position paper “The Use of emergency…

|

War in Ukraine: European Parliament calls to ensure access to emergency contraception for women throughout conflict and displacement.

May 2022. On May 5th, the European Parliament adopted a resolution that strongly condemns the use of sexual and gender-based violence as a weapon of war. Members of the European Parliament (MEPs) call on the EU and host and transit countries to guarantee access to sexual and reproductive health and rights services, particularly emergency contraception,…

Launch of the State of World Population 2022 report

March 2022. The neglected crisis of unintended pregnancy is the subject of UNFPA’s flagship 2022 State of World Population report, released on March 30, 2022. Titled “Seeing the Unseen,” the report examines how such pregnancies represent a global failure to uphold basic human rights. Nearly half of all pregnancies, totalling 121 million each year throughout…

Ukraine: urgent Call to Action

March, 2022. An urgent Call to Action has been issued by over 60 global and national organizations from Hungary, Moldova, Poland, Romania, Slovakia and Ukraine, calling on decision makers in Europe and internationally, to act swiftly to protect the human rights and address the sexual and reproductive health needs of women and girls and marginalized…

|

Over-the-counter provision of EC pills is feasible

March 2022.  A new systematic review of over-the-counter (OTC) provision of emergency contraception pills (ECPs), concludes that it is feasible and acceptable, and that it may increase access to and timely use of effective contraception. Evidence suggests that OTC provision of ECPs do not substantively change reproductive health outcomes. This review expands the evidence supporting…